Showing results (361-370 of 414) with videos related to

Sort By:
Pageof 42
Haematologica|February 9, 2012
CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAILUte Fischer, Christian Ruckert, Bernd Hubner, et al.
European Heart Journal|July 1, 1997
PTCA registry of German community hospitals. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) Study GroupA Vogt, T Bonzel, D Harmjanz, et al.
Advances in Wound Care|May 22, 2024
Testosterone Promotes Nerve Tethering and Acellular Biomaterial Perineural Fibrosis in a Rat Wound Repair ModelCalvin R Schuster, Erik Reiche, Patrick R Keller, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 15, 2026
From framework to practice: applying the proteus-practice framework to learn lessons for integrating PROs in clinical careAnne L R Schuster, Claire Snyder, Lotte Haverman, et al.
The Journal of Craniofacial Surgery|April 18, 2025
Moving to 3D: Quantifying Virtual Surgical Planning Accuracy Using Geometric Morphometrics and Cephalometrics in Facial Feminization SurgerySophia Hu, Julie Lawrence, Calvin R Schuster, et al.
Physical Review Letters|June 4, 2008
Pseudogap and charge density waves in two dimensionsS V Borisenko, A A Kordyuk, A N Yaresko, et al.
Physical Review Letters|December 31, 2008
Optical study of LaO0.9F0.1FeAs: evidence for a weakly coupled superconducting stateS-L Drechsler, M Grobosch, K Koepernik, et al.
Cancer Genomics & Proteomics|January 9, 2009
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cellsFriedhelm R Schuster, Raymund Buhmann, Susanne Reuther, et al.
Clinical and Experimental Immunology|October 30, 2014
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsO Guttman, B M Baranovski, R Schuster, et al.
Blood|July 29, 1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapyJ Drach, J Ackermann, E Fritz, et al.
Pageof 42